MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ASMB — Assembly Biosciences, Inc
NasdaqAssembly Biosciences, Inc
$22.54
-0.44(-1.91%)
- O
- 23.30
- H
- 23.48
- L
- 22.01
- V
- 367.96K
⏱️ End-of-day dataAs of Oct 2, 2026
ASMB — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash And Cash Equivalents | $31.12M | $58.45M | $22.53M | $24.01M | $23.41M | $38.34M |
| Other Short Term Investments | $19.55M | $18.97M | $21.00M | $50.97M | $67.61M | $73.73M |
| Accounts Receivable | 451,000.00 | 974,000.00 | 912,000.00 | N/A | N/A | 0.00 |
| Other Current Assets | $5.56M | $5.47M | $3.34M | $2.49M | $4.50M | $3.42M |
| Total Current Assets | $23.26M | $25.45M | $23.68M | $77.47M | $95.53M | $11.55M |
| Properties | $2.58M | $2.73M | $2.87M | $3.00M | $3.18M | $3.35M |
| Other Non Current Assets | 312,000.00 | 312,000.00 | 312,000.00 | 312,000.00 | 312,000.00 | 312,000.00 |
| Total Non Current Assets | $2.90M | $3.04M | $3.19M | $3.31M | $3.49M | $3.67M |
| Total Assets | $23.55M | $25.76M | $24.00M | $80.78M | $99.02M | $11.92M |
| Accounts Payable | $1.13M | $1.17M | $1.68M | 743,000.00 | 875,000.00 | 585,000.00 |
| Accrued Expenses | $1.84M | $2.61M | $3.73M | $2.06M | $2.58M | $2.66M |
| Short Term Debt | 590,000.00 | 569,000.00 | 548,000.00 | 533,000.00 | 529,000.00 | 461,000.00 |
| Deferred Revenue | $29.08M | $36.90M | $42.36M | $40.92M | $40.82M | $37.62M |
| Pensions | $2.37M | $7.52M | $5.05M | $3.04M | $1.82M | $6.48M |
| Total Current Liabilities | $35.00M | $48.78M | $53.38M | $47.29M | $46.63M | $47.80M |
| Long Term Debt | $1.90M | $2.06M | $2.21M | $2.35M | $2.49M | $2.63M |
| Total Non Current Liabilities | $1.90M | $2.06M | $3.92M | $15.39M | $25.25M | $38.01M |
| Total Liabilities | $36.90M | $50.84M | $57.30M | $62.68M | $71.88M | $85.81M |
| Common Stock | 16,000.00 | 16,000.00 | 16,000.00 | 8,000.00 | 8,000.00 | 7,000.00 |
| Retained Earnings | $-84.11M | $-83.20M | $-85.41M | $-84.49M | $-83.47M | $-82.59M |
| Other Shareholders Equity | -368,000.00 | -41,000.00 | -90,000.00 | -279,000.00 | -253,000.00 | -211,000.00 |
| Total Shareholders Equity | $19.86M | $20.68M | $18.27M | $18.10M | $27.13M | $33.36M |
| Additional Paid In Capital | $104.01M | $103.88M | $103.69M | $86.33M | $86.21M | $85.95M |